"Supreme Court Abortion Pill Case: Key Takeaways and Live Updates"

The Supreme Court appeared skeptical of efforts to restrict access to mifepristone, a key medication used in over 60% of U.S. abortions, as it heard a case challenging the government's loosening of regulations. Justices questioned whether the antiabortion doctors challenging the regulations have sufficient legal grounds to bring the lawsuit. The case comes less than two years after the conservative majority overturned Roe v. Wade. Mifepristone, approved by the FDA for use through 10 weeks' gestation, is one of two drugs that work together to terminate a pregnancy. The pharmaceutical industry has warned that second-guessing the FDA's determinations in this case could disrupt the nation's drug-approval process and stymie private investments in drug research.